Paget's Disease of the Breast

April 2013
Rhode Island Medical Journal;Apr2013, Vol. 96 Issue 4, p50
Academic Journal
Case Study
The article presents a case study of a 61-year old female diagnosed from Paget's disease of the breast. The female has undergone skin biopsy which reveals that she has Paget's disease of the nipple, which was estrogen receptor negative and progesterone receptor positive. The patient underwent mastectomy and sentinel lymph node biopsy which shows high grade ductal carcinoma in situ (DCIS).


Related Articles

  • Cancer du sein après lymphome de Hodgkin. Cutuli, B. // Oncologie;Jun2012, Vol. 14 Issue 6/7, p395 

    No abstract available.

  • Morphological profile and receptor status in breast carcinoma: An institutional study. Rao, Chandrika; Shetty, Jayaprakash; HL, Kishan Prasad // Journal of Cancer Research & Therapeutics;Jan-Mar2013, Vol. 9 Issue 1, p44 

    Context: The data on histological and receptor status in breast cancer in an Indian population is limited as receptor status is not routinely carried out for these patients. In the present study, receptor status was analyzed and it was correlated with morphological prognostic parameters....

  • Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers. Van der Groep, P.; Diest, P. J. van; Menko, F. H.; Bart, J.; De Vries, E. G. E.; Van der Wall, E. // Journal of Clinical Pathology;Oct2009, Vol. 62 Issue 10, p926 

    AIMS: Ductal carcinoma in situ (DCIS) is an established late precursor of sporadic invasive breast cancer and to a large extent parallels its invasive counterpart with respect to molecular changes and immunophenotype. Invasive breast cancers in germline BRCA1 and BRCA2 mutation carriers have a...

  • Biofunctional characteristics of in situ and invasive breast carcinoma. Bravaccini, Sara; Granato, Anna; Medri, Laura; Foca, Flavia; Falcini, Fabio; Zoli, Wainer; Ricci, Monica; Lanzanova, Giuseppe; Masalu, Nestory; Serra, Luigi; Buggi, Federico; Folli, Secondo; Silvestrini, Rosella; Amadori, Dino // Cellular Oncology (2211-3428);Jul2013, Vol. 36 Issue 4, p303 

    Purpose: The increasing use of breast-conserving surgery makes it essential to identify biofunctional profiles responsible for the progression of in situ to invasive carcinomas to facilitate the detection of lesions that are most likely to relapse or progress and, thus, to be able to offer...

  • Clinicopathological study of centrally necrotizing carcinoma of the breast. Yanling Zhang; Yurong Ou; Donghong Yu; Xiang Yong; Xiaoli Wang; Bo Zhu; Qiong Zhang; Lei Zhou; Zhaogen Cai; Zenong Cheng // BMC Cancer;2015, Vol. 15 Issue 1, p1 

    Background: Centrally necrotizing carcinoma of the breast (CNC) represents a newly-identified subset of breast cancer. The clinical and pathological characteristics of this breast cancer subtype are not yet completely understood. Methods: We assessed the clinicopathological characteristics of 73...

  • Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype. Patani, Neill; Barbashina, Violetta; Lambros, Maryou B. K.; Gauthier, Arnaud; Mansour, Marthe; Mackay, Alan; Reis-Filho, Jorge S. // Journal of Clinical Pathology;Sep2011, Vol. 64 Issue 9, p822 

    Triple-negative breast cancers account for 12-17% of all invasive breast carcinomas and comprise a heterogeneous group of tumours, with varying histological features and clinical behaviours. Focal apocrine differentiation can be associated with a subset of these lesions. To establish whether...

  • Vimentin as a poor prognostic factor for triple-negative breast cancer. Yamashita, Nami; Tokunaga, Eriko; Kitao, Hiroyuki; Hisamatsu, Yuichi; Taketani, Kenji; Akiyoshi, Sayuri; Okada, Satoko; Aishima, Shinichi; Morita, Masaru; Maehara, Yoshihiko // Journal of Cancer Research & Clinical Oncology;May2013, Vol. 139 Issue 5, p739 

    Purpose: Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, is a highly heterogeneous disease. Recent studies suggest that there are links between TNBC and the epithelial-mesenchymal...

  • ASSESSMENT OF PROTEASE ACTIVATED RECEPTOR-1 (PAR-1) EXPRESSION IN BREAST CANCER PATIENTS AND CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS. Koumoundourou, Dimitra; Michail, G.; Zervoudis, S.; Maragoudakis, M. E.; Tsopanoglou, N.; Kourounis, G.; Ravazoula, Panagiota // Acta Endocrinologica (1841-0987);Oct-Dec2005, Vol. 1 Issue 4, p383 

    Previous studies have correlated the expression of PAR proteins with breast cancer invasiveness. The scope of this study was to evaluate the expression of PAR-1 in human breast cancer specimens and investigate possible correlations with tumor size, grade and lymph node status, as well as...

  • Paget disease of the male nipple. El Harroudi, T.; Tijami, F.; El Otmany, A.; Jalil, A. // Journal of Cancer Research & Therapeutics;Jan-Mar2010, Vol. 6 Issue 1, p95 

    Breast cancer occurring in the mammary gland of men is infrequent. It accounts for 0.8% of all breast cancers, which is less than one per cent of all newly diagnosed male cancers and 0.2% of male cancer deaths. However, Paget disease of the male nipple is extremely rare. We report a single case...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics